Related references
Note: Only part of the references are listed.Characterization of Human Cancer Cell Lines by Reverse-phase Protein Arrays
Jun Li et al.
CANCER CELL (2017)
Proteogenomics connects somatic mutations to signalling in breast cancer
Philipp Mertins et al.
NATURE (2016)
Proteomic maps of breast cancer subtypes
Stefka Tyanova et al.
NATURE COMMUNICATIONS (2016)
System-wide Clinical Proteomics of Breast Cancer Reveals Global Remodeling of Tissue Homeostasis
Yair Pozniak et al.
CELL SYSTEMS (2016)
Comparative analysis of statistical methods used for detecting differential expression in label-free mass spectrometry proteomics
Sarah R. Langley et al.
JOURNAL OF PROTEOMICS (2015)
The Proteomic Landscape of Triple-Negative Breast Cancer
Robert T. Lawrence et al.
CELL REPORTS (2015)
MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis
Atsushi Terunuma et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Integrating Meta-Analysis of Microarray Data and Targeted Proteomics for Biomarker Identification: Application in Breast Cancer
Maria P. Pavlou et al.
JOURNAL OF PROTEOME RESEARCH (2014)
Proteogenomic characterization of human colon and rectal cancer
Bing Zhang et al.
NATURE (2014)
An integrated genomics approach identifies drivers of proliferation in luminal-subtype human breast cancer
Michael L. Gatza et al.
NATURE GENETICS (2014)
Demonstrating the feasibility of large-scale development of standardized assays to quantify human proteins
Jacob J. Kennedy et al.
NATURE METHODS (2014)
Dynamic analyses of alternative polyadenylation from RNA-seq reveal a 3′- UTR landscape across seven tumour types
Zheng Xia et al.
NATURE COMMUNICATIONS (2014)
PAM50 proliferation score as a predictor of weekly paclitaxel benefit in breast cancer
Miguel Martin et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Quantitative Proteomic Analysis of Microdissected Breast Cancer Tissues: Comparison of Label-Free and SILAC-based Quantification with Shotgun, Directed, and Targeted MS Approaches
Ning Qing Liu et al.
JOURNAL OF PROTEOME RESEARCH (2013)
Proteomics of Genetically Engineered Mouse Mammary Tumors Identifies Fatty Acid Metabolism Members as Potential Predictive Markers for Cisplatin Resistance
Marc Warmoes et al.
MOLECULAR & CELLULAR PROTEOMICS (2013)
Identification of Multiple Novel Protein Biomarkers Shed by Human Serous Ovarian Tumors into the Blood of Immunocompromised Mice and Verified in Patient Sera
Lynn A. Beer et al.
PLOS ONE (2013)
Pathway-based personalized analysis of cancer
Yotam Drier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Myc and mTOR converge on a common node in protein synthesis control that confers synthetic lethality in Myc-driven cancers
Michael Pourdehnada et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Proteomic Portrait of Human Breast Cancer Progression Identifies Novel Prognostic Markers
Tamar Geiger et al.
CANCER RESEARCH (2012)
A Xenograft Mouse Model Coupled with In-depth Plasma Proteome Analysis Facilitates Identification of Novel Serum Biomarkers for Human Ovarian Cancer
Hsin-Yao Tang et al.
JOURNAL OF PROTEOME RESEARCH (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
Global quantification of mammalian gene expression control
Bjoern Schwanhaeusser et al.
NATURE (2011)
MYC as a regulator of ribosome biogenesis and protein synthesis
Jan van Riggelen et al.
NATURE REVIEWS CANCER (2010)
Widespread Shortening of 3′UTRs by Alternative Cleavage and Polyadenylation Activates Oncogenes in Cancer Cells
Christine Mayr et al.
CELL (2009)
Correlation of mRNA and protein in complex biological samples
Tobias Maier et al.
FEBS LETTERS (2009)
A Core MYC Gene Expression Signature Is Prominent in Basal-Like Breast Cancer but Only Partially Overlaps the Core Serum Response
Sanjay Chandriani et al.
PLOS ONE (2009)
Association of breast cancer outcome with status of p53 and MDM2 SNP309
Brenda J. Boersma et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
S Paik et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Bioconductor: open software development for computational biology and bioinformatics
RC Gentleman et al.
GENOME BIOLOGY (2004)
A gene-expression signature as a predictor of survival in breast cancer.
MJ van de Vijver et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
Share Paper
